Becton Dickinson AB
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Becton Dickinson AB
Embecta, which recently completed its spin-off from Becton Dickinson, is forging ahead with its insulin injector-based business strategy, GLP-1s be damned.
The 2023 LSX Congress in Boston, MA, heard the views of top-tier medtechs BD, GE HealthCare and Merit Medical as they outlined sustainability compliance strategies and goal setting mechanisms, as summarized in this latest contribution to In Vivo’s rolling series on “The E in ESG.”
Paolo Di Vincenzo, the general manager of Smith+Nephew's US advanced wound management business will join Medtronic as the president of its neuromodulation business.
For medtechs, implementing an ESG strategy will need to become a priority as global rules are being introduced for companies to report ESG data. A panel discussion with medtech ESG leaders at the recent LSX Congress USA conference in Boston outlined some strategies and sustainability goals.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.